These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 24618304

  • 21. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB, Barclay ML.
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [Abstract] [Full Text] [Related]

  • 22. Review article: the role of non-biological drugs in refractory inflammatory bowel disease.
    Ng SC, Chan FK, Sung JJ.
    Aliment Pharmacol Ther; 2011 Feb; 33(4):417-27. PubMed ID: 21138457
    [Abstract] [Full Text] [Related]

  • 23. Thiopurines in inflammatory bowel disease revisited.
    Bär F, Sina C, Fellermann K.
    World J Gastroenterol; 2013 Mar 21; 19(11):1699-706. PubMed ID: 23555158
    [Abstract] [Full Text] [Related]

  • 24. A validated HPLC method for the monitoring of thiopurine metabolites in whole blood in paediatric patients with inflammatory bowel disease.
    Cangemi G, Barabino A, Barco S, Parodi A, Arrigo S, Melioli G.
    Int J Immunopathol Pharmacol; 2012 Mar 21; 25(2):435-44. PubMed ID: 22697075
    [Abstract] [Full Text] [Related]

  • 25. New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
    Khan A, Berahmana AB, Day AS, Barclay ML, Schultz M.
    N Z Med J; 2019 Mar 08; 132(1491):46-62. PubMed ID: 30845128
    [Abstract] [Full Text] [Related]

  • 26. Thiopurine metabolism monitoring: implications in inflammatory bowel diseases.
    Dewit O, Starkel P, Roblin X.
    Eur J Clin Invest; 2010 Nov 08; 40(11):1037-47. PubMed ID: 20629710
    [Abstract] [Full Text] [Related]

  • 27. Late-onset Rise of 6-MMP Metabolites in IBD Patients on Azathioprine or Mercaptopurine.
    Munnig-Schmidt E, Zhang M, Mulder CJ, Barclay ML.
    Inflamm Bowel Dis; 2018 Mar 19; 24(4):892-896. PubMed ID: 29522107
    [Abstract] [Full Text] [Related]

  • 28. Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study.
    Kanis SL, de Lima-Karagiannis A, de Boer NKH, van der Woude CJ.
    Clin Gastroenterol Hepatol; 2017 Aug 19; 15(8):1232-1241.e1. PubMed ID: 28342949
    [Abstract] [Full Text] [Related]

  • 29. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
    Al Hadithy AF, de Boer NK, Derijks LJ, Escher JC, Mulder CJ, Brouwers JR.
    Dig Liver Dis; 2005 Apr 19; 37(4):282-97. PubMed ID: 15788214
    [Abstract] [Full Text] [Related]

  • 30. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
    Hindorf U, Lyrenäs E, Nilsson A, Schmiegelow K.
    Scand J Gastroenterol; 2004 Nov 19; 39(11):1105-12. PubMed ID: 15545169
    [Abstract] [Full Text] [Related]

  • 31. Thiopurine Metabolism in the Era of Combotherapy.
    Roblin X, Williet N, Peyrin-Biroulet L.
    Inflamm Bowel Dis; 2016 Jun 19; 22(6):1496-501. PubMed ID: 26978723
    [Abstract] [Full Text] [Related]

  • 32. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
    Ansari A, Patel N, Sanderson J, O'Donohue J, Duley JA, Florin TH.
    Aliment Pharmacol Ther; 2010 Mar 19; 31(6):640-7. PubMed ID: 20015102
    [Abstract] [Full Text] [Related]

  • 33. Thiopurine metabolite testing in inflammatory bowel disease.
    Goldberg R, Moore G, Cunningham G, Schulberg J, Marsh P, Brown S, Connell W, Lust M, Kamm MA, Bell S.
    J Gastroenterol Hepatol; 2016 Mar 19; 31(3):553-60. PubMed ID: 26510636
    [Abstract] [Full Text] [Related]

  • 34. Thiopurine monitoring in children with inflammatory bowel disease: a systematic review.
    Konidari A, Anagnostopoulos A, Bonnett LJ, Pirmohamed M, El-Matary W.
    Br J Clin Pharmacol; 2014 Sep 19; 78(3):467-76. PubMed ID: 24592889
    [Abstract] [Full Text] [Related]

  • 35. Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease.
    Smith MA, Irving PM, Marinaki AM, Sanderson JD.
    Aliment Pharmacol Ther; 2010 Jul 19; 32(2):119-30. PubMed ID: 20412066
    [Abstract] [Full Text] [Related]

  • 36. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
    Jharap B, de Boer NK, Stokkers P, Hommes DW, Oldenburg B, Dijkstra G, van der Woude CJ, de Jong DJ, Mulder CJ, van Elburg RM, van Bodegraven AA, Dutch Initiative on Crohn and Colitis.
    Gut; 2014 Mar 19; 63(3):451-7. PubMed ID: 23424097
    [Abstract] [Full Text] [Related]

  • 37. Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD.
    de Boer NK, van Bodegraven AA, Jharap B, de Graaf P, Mulder CJ.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec 19; 4(12):686-94. PubMed ID: 18043678
    [Abstract] [Full Text] [Related]

  • 38. Thiopurines and myeloid disorders: is more caution needed when treating inflammatory bowel disease patients?
    Lopez A, Beaugerie L, Peyrin-Biroulet L.
    Expert Rev Clin Immunol; 2014 Dec 19; 10(12):1563-5. PubMed ID: 25362886
    [Abstract] [Full Text] [Related]

  • 39. Vitamin A and inflammatory bowel diseases: from cellular studies and animal models to human disease.
    Barbalho SM, Goulart RA, Batista GLDSA.
    Expert Rev Gastroenterol Hepatol; 2019 Jan 19; 13(1):25-35. PubMed ID: 30791845
    [Abstract] [Full Text] [Related]

  • 40. Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis.
    Czaja AJ.
    Aliment Pharmacol Ther; 2020 Jun 19; 51(12):1286-1304. PubMed ID: 32363674
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.